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Conclusions: On account of old age and some of them had given up aggres-
sive treatments, antimicrobial adjustment by IDs’ recommendation showed
only marginal effects against fatality. Under such circumstances, it should
be more prudent to prescribe antibiotics.
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Purpose: Multidrug resistant Acinetobacter baumannii is one of the most
common cause of hospital acquired infection (HAIs) in intensive care units
(ICUs) worldwide and commonly associated with increasing mortality and
length of stay. To address with the increasing of multi-drug resistant A.bau-
mannii infection, antimicrobial stewardship programmes are promoted
worldwide to encourage judicious antimicrobial use and prevent the emer-
gence of resistance. The aim of this study is to determine the impact of
the antimicrobial stewardship programmes in preventing the development
of A. baumannii antimicrobial resistance.
Methods: During the period from June 2012 till June 2013, A. baumanii iso-
lates data from sputum, wound, blood, urine, and cerebro-spinal fluid were
collected and used as a baseline data. The identification of A.baumannii and
resistant pattern was performed by using VITEX 2 Compact according to
Clinical Laboratory and Standards Institute (CLSI). Socialization and imple-
mentation of the antimicrobial stewardship programmes including; (1)
determining the empirical antimicrobial drug use in the ICU, (2) using the
antibiotic prescription chart to ensure antibiotic prescription based on
microbiological culture and sensitivity.
Results: From the baseline data, A baumannii found in 16 isolates and were
multidrug resistant. The majority of the isolates sensitive to colistin (100%)
and cefoporazone/sulbactame (77%). After the implementation of antimi-
crobial stewardship programmes, the incidence of A.baumannii finding
was decreasing into 3 isolates and showed the increasing sensitivity to cefo-
porazone/sulbactame (89%) that use as empirical therapy for gram negative
bacteria infection in the ICU. The sensitivity to the other antimicrobial; car-
bapenem, imipenem, meropenem, aminoglycoside were also increasing.
Conclusions: Our result of the antimicrobial stewardship programmes
showed the improvement A.baumannii sensitivity to the first-line antimicro-
bials. To have the antimicrobial stewardship programmes helped us to
decrease the rate of bacterial resistance within our hospital.
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Purpose: Levofloxacin belongs to the third-generation Fluoroquinolones
(FQs). It is not only the broad-spectrum antibiotic for G (＋) and G ()
(Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa) but also
more activity to the atypical bacteria (Chlamydia, Mycoplasma). In this
retrospective study, we evaluated the converting ratio between injection
and oral forms. This drug utilizing evaluation (DUE) study will help to elevate
the reasonable using of levofloxacin in the hospital.
Methods: This study is a retrospective study in a regional hospital. Cases
were collected from April 2014 to June 2014 for all hospitalized patients us-
ing Levofloxacin. The reasonableness assessment of Levofloxacin prescribing
included indications, doses, bacterial culture or consulted with Infectious
Diseases physician. The recommendation doses for renal dysfunction fol-
lowed by SANFORD GUIDE. Patient’s creatinine clearance (Clcr) was
monitoring for adjusting the therapeutic dose accordingly. Descriptive sta-
tistical analysis was performed in the study.
Results: Total 158 cases were recruited in the study. The bacterial culture was
performed in 157 cases (99.4%). Depending on bacterial culture results, consid-
ering as reasonable using levofloxacinwas 86 cases (54.4% ), and empirical ther-
apy counted as 61 (38.6% ), which were also consulted with Infectious Diseases
physician prior to administration. In addition, 158 cases (100%) were monitored
Clcr, 143 cases (90.5%) had performed dose adjustments in accordance with
appropriate therapeutic doses by renal function. Moreover, 23 cases used injec-
tion form over 7 days during hospitalization period, 3 cases (13.0%) switched to
oral form during hospitalization period, 12 cases (52.2%) did not switch during
hospitalization period, 8 cases of them (8/23, 34.8%) did not switch during hos-
pitalization period but took home with oral levofloxacin.
Conclusion: This study showed that the reasonableness of the use of Levo-
floxacin was counted as 86 cases (54.4%). The ratio of injection dosage
form converted to oral form was not ideally. The results will provide physi-
cians to use the build-in computerized physician order entry system remind-
ing to improve the efficacy of levofloxacin.
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Purposes: The aim of this study was to evaluate the appropriateness of
piperacillin/ tazobactam (Tapimycin; YUNGSHIN, Taichung, TW) usage in
a regional hospital, retrospectively.
Methods: This retrospective study was designed to recurit all patients
admitted to the regional hospital with prescribing Tapimycin from
October, 2013 to December, 2013. The electronic medical records were
reviewed and studied, respectively. We collected patient’s data including
demographics, empirical indication, infusion time, dose and dosing inter-
val, culture and susceptible results, concomitant antibiotics, and de-esca-
lation of the antimicrobial regimen. The endpoint of overall
appropriateness was evaluated and dose adjustment following renal func-
tion monitoring by creatinine clearance (Clcr) calculated by Cockcroft-
Gault Equation.
Results: During this period, 181 cases, 112 female cases and 69 male cases
were obtained from 159 patients. The average age of the cases was 67.4 
16.59. The average administration day was 10.01  4.25. The main indica-
tion for initiation administration was pneumonia (109/181; 60%). There
were 41 (41/360, 11.39%) isolations as Pseudomonas aeruginosa; 35 (35/
360, 9.72%) were Klebsiella pneumoniae; 21 (21/360, 5.83%) were Escher-
ichia coli. Thirty-seven (20.44%) cases infusion time were longer than 60
min. There were 111 cases (61.33%) with normal renal function. Renal
dysfunction with dosage adjustment was counted as 51 cases (28.18%).
However, there were 13 cases (7.18%) with renal dysfunction without
dose or dosing interval adjustment. At the endpoint of evaluation, 72 cases
(40%) where antibiotics were changed to narrow-spectrum antimicrobials
or oral antibiotics were considered as de-escalation. The overall rate of
appropriateness of Tapimycin therapy was 138/181 (76%).
Conclusion: Our results present the tendency toward the appropriate rate of
Tapimycin utilization at our institution was only 76%, especially, when the
selection of treatment based on initial empirical therapy was inappropriate.
Without dosing adjustment was given the concerns about the increasing
occurrence of antibiotic adverse events. Further studies may be performed
to establish guidance ideally in the future.
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Purpose: Patients with chronic obstructive pulmonary disease (COPD) have
an increased incidence of pneumonia caused by Pseudomonas aeruginosa.
A respiratory fluoroquinolones alone or a beta-lactam plus a macrolide is
recommended in the presence of comorbidities according to Infectious Dis-
eases Society of America/American Thoracic Society guideline for commu-
nity-acquired pneumonia. However, few studies have directly compared
the two regimens. The present study aimed to compare the risk of pneu-
monia-related hospitalization in COPD patients treated with fluoroquino-
lones versus b-lactam/b-lactamase inhibitor combinations.
Methods: We conducted a retrospective cohort study and identified 19,876 ep-
isodes of COPD with pneumonia in the outpatients from the Taiwan National
Health Insurance Research Database (NHIRD) during 2002e2011. Using the pro-
pensity score analysis, patients receiving fluoroquinolones and b-lactam/b-lac-
tamase inhibitor combinations were matched for baseline covariates (n Z
1,296 episodes for each groups). The primary outcome was pneumonia-related
hospitalization more than 3 days after receiving antibiotics, while the second-
ary outcomes were treatment failure, 30-day mortality and medical costs.
Results: The rate of pneumonia-related hospitalization was 3.9% in the fluo-
roquinolone group and 3.5% in the b-lactam/b-lactamase inhibitor combina-
tion group (adjusted hazard ratio [HR], 1.11; 95% confidence interval [CI],
0.74e1.66). Compared with b-lactam/b-lactamase inhibitor combinations,
fluoroquinolones did not offer less treatment failure (28.2% vs. 31.3%; HR,
0.86; 95% CI, 0.73e1.02) and 30-day mortality (0.5% vs. 0.4%; HR, 1.40;
95% CI, 0.45e4.41). The total medical costs (15,847 vs. 13,644 Taiwan dol-
lars) and pneumonia-related costs (6,060 vs. 4,646 Taiwan dollars) were
similar between these two groups (both P > 0.05).
Conclusions: InCOPDoutpatientswithpneumonia,fluoroquinoloneswereasso-
ciated with similar outcomes compared with b-lactam/b-lactamase inhibitor
combinations. Our findings supported the current consensus recommendations.
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Purpose: Ciprofloxacin is a broad spectrum fluoroquinolone antimicrobial
agent. Dose adjustments to prevent toxicity effects recommended in pa-
tients with impaired renal function are various among countries. Prescribing
rationally will help to ensure the clinical utilization of this valuable antimi-
crobial drug continuously.
Methods: We conducted a retrospective study of the Ciprofloxacin usage
appropriately on 112 patients between March, 2014 and June, 2014, at a
Regional Teaching Hospital in Taichung. Assessment criteria of the Ciproflox-
acin using rationality included indication, bacterial culture and dosage forms
conversion. Cockcroft and Gault Equation calculating creatinine clearance
was used to assess patients’ renal function referring to 2013 SANFORD GUIDE
in accordance with dose adjustment in the study. Descriptive statistical
analysis has been performed.
Results: Themeanageofthesepatientswas54.5( 19.35). In thesepatients,43
of 112 (38.4%) were infectious gastroenteritis, 22 of 112 (19.6%) were urinary
tract infections, and 11 of 112 (9.8%) were neutropenia. There were 42 people
(37.5%) growth nothing in the culture, Pseudomonoas aeruginosa in total of 16
(14.3 %), and Escherichia coli in total of 9 people (8%). Five over 18 people
(27.8%) converted from injection administration to oral medication so the con-
version rate was not ideal in the hospital. The proportion of giving appropriate
dosefor renaldysfunctionpatientswas56.1% (23/41people).Thus, the study re-
sults in Ciprofloxacin reasonableness using was considered as 83.9% (94/112).
Conclusion: At present, based on the computerized physician order entry
(CPOE) system, dose adjustment was implemented on renal function impair-
ment patients directly when physicians prescribe ciprofloxacin on March
2014. The reasonable performance in the Ciprofloxacin utilization is 83.9%
currently. The higher rationality rate is expected in the future in order to
provide patients with effectiveness antimicrobial treatment and protect pa-
tients’ medication utilizing safety.
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Purpose: Excessive antibiotic consumption results in bacterial antibiotic
resistance and is a financial burden. The effect of a new antibiotic restric-
tion policy with an antimicrobial stewardship program (ASP) was assessed
in this study.
Methods: A cohort study of the ASP instituted in Nan Men general hospital, a
141-bed local hospital in Taiwan, was designed to compare pharmaceutical,
microbiological and financial changes during a 3-year period from 2011 to
2013. The cost of antimicrobials, defined daily dose (DDD) and susceptibility
to 13 antibiotics prescribed were calculated and evaluated before and after
the ASP implementation since January 1, 2012.
Results: The average monthly cost of antibiotics decreased 37.0% from
$30146.8 in 2011 to $18993.2 in 2012 (P < 0.001), and it also decreased
from 2012 to 2013 by 15.6% from $18993.2 to $16021.3 (P Z 0.022) (Figure
1). Antibiotic resistances of the two most common bacteremia found in lab-
oratory of this hospital, Escherichia coli (E. coli) and Klebsiella pneumoniae
(K. pneumoniae), were examined. The new antibiotic restriction policy
decreased or maintained antibiotic resistance to 10 antibiotics (76.9%)
against E. coli and all 13 antibiotics (100%) for K. pneumoniae. Total intrave-
nous antibiotic DDDs of the inpatients were 21932, 16816 and 14541 in 2011,
2012 and 2013, respectively. The yearly sum of all intravenous antibiotic
DDDs of all intravenous antibiotics decreased by 7391.8 from 2011 to 2013.
Total intravenous antibiotic DDDs per 100 bed-days of the inpatients were
67.1, 55.0 and 49.4 in 2011, 2012 and 2013, respectively. A total of 17.1
DDDs per 100 bed-days of inpatients decreased while from 2011 to 2013.
Figure 1 (A) The average antimicrobial cost in each month from 2011 to
2013. * Antimicrobial cost Z data*104 dollars (B) The percentage of antimi-
crobial cost in comparison to total cost of all drugs in each month.
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